Treatment for childhood rhabdomyosarcoma: the cost of cure. (Q36026113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Treatment for childhood rhabdomyosarcoma: the cost of cure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

Childhood Rhabdomyosarcoma

8 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Michael C G Stevens

series ordinal

1

1 reference

11 August 2017

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

77-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

8 January 2020

review article

1 reference

Health Status of Adult Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Survival of children with soft-tissue sarcoma in Europe since 1978

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

The Intergroup Rhabdomyosarcoma Study-II.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

The Third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Radiation therapy for rhabdomyosarcoma: Local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Intensive Induction Chemotherapy and Delayed Irradiation in the Management of Parameningeal Rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901733-X

7 January 2021

10.1016/S1470-2045(05)01733-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15683816%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference